Citadel Advisors’s MEDASSETS INC COM STK (DE) MDAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-700
Closed -$22K 9125
2015
Q4
$22K Sell
700
-3,000
-81% -$83.4K ﹤0.01% 7875
2015
Q3
$74K Sell
3,700
-3,700
-50% -$78.8K ﹤0.01% 7256
2015
Q2
$163K Buy
7,400
+4,900
+196% +$102K ﹤0.01% 6575
2015
Q1
$47K Sell
2,500
-1,000
-29% -$19K ﹤0.01% 7423
2014
Q4
$69K Buy
3,500
+1,300
+59% +$26.4K ﹤0.01% 6966
2014
Q3
$46K Buy
2,200
+800
+57% +$17.9K ﹤0.01% 6956
2014
Q2
$32K Buy
1,400
+600
+75% +$14K ﹤0.01% 7052
2014
Q1
$20K Sell
800
-1,700
-68% -$38.3K ﹤0.01% 7299
2013
Q4
$50K Buy
2,500
+1,800
+257% +$40.5K ﹤0.01% 6041
2013
Q3
$18K Hold
700
﹤0.01% 6285
2013
Q2
$12K Buy
+700
New +$12.6K ﹤0.01% 6206

Citadel Advisors's MDAS Position: Q1 2016 in Review

Citadel Advisors sold out of MEDASSETS INC COM STK (DE) (MDAS) in Q1 2016, closing a stake of 7,657 shares — an estimated $237K sold.

Citadel Advisors first reported a position in MDAS in Q2 2013 and held it in 11 quarters. The position peaked at $8.46M in Q1 2015. 0 funds tracked by Wall St. Rank hold MDAS as of Q1 2016.

  • Citadel Advisors reported no remaining MEDASSETS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Citadel Advisors sold 7,657 MEDASSETS INC COM STK (DE) shares in Q1 2016, an estimated $237K.
  • Citadel Advisors first reported a position in MEDASSETS INC COM STK (DE) in Q2 2013 and held it in 11 quarters.
  • Citadel Advisors's MEDASSETS INC COM STK (DE) position peaked at $8.46M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held MEDASSETS INC COM STK (DE) as of Q1 2016.

Based on Citadel Advisors's 13F filing for Q1 2016, filed 13 May 2016.